| A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer PA Ott, S Hu-Lieskovan, B Chmielowski, R Govindan, A Naing, ... Cell 183 (2), 347-362. e24, 2020 | 418 | 2020 |
| Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit KH Bremner, J Scherer, J Yi, M Vershinin, SP Gross, RB Vallee Cell host & microbe 6 (6), 523-535, 2009 | 207 | 2009 |
| Mutually exclusive cytoplasmic dynein regulation by NudE-Lis1 and dynactin RJ McKenney, SJ Weil, J Scherer, RB Vallee Journal of Biological Chemistry 286 (45), 39615-39622, 2011 | 139 | 2011 |
| Recruitment of dynein to late endosomes and lysosomes through light intermediate chains SC Tan, J Scherer, RB Vallee Molecular biology of the cell 22 (4), 467-477, 2011 | 112 | 2011 |
| PKA-dependent dynein switching from lysosomes to adenovirus: a novel form of host–virus competition J Scherer, J Yi, RB Vallee Journal of Cell Biology 205 (2), 163-177, 2014 | 72 | 2014 |
| Exocytosis of alphaherpesvirus virions, light particles, and glycoproteins uses constitutive secretory mechanisms IB Hogue, J Scherer, LW Enquist MBio 7 (3), 10.1128/mbio. 00820-16, 2016 | 57 | 2016 |
| Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon J Scherer, RB Vallee Viruses 3 (8), 1417-1431, 2011 | 56 | 2011 |
| Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon J Scherer, RB Vallee Viruses 3 (8), 1417-1431, 2011 | 56 | 2011 |
| Fluorescent protein approaches in alpha herpesvirus research IB Hogue, JB Bosse, EA Engel, J Scherer, JR Hu, T Del Rio, LW Enquist Viruses 7 (11), 5933-5961, 2015 | 42 | 2015 |
| Role of kinesins in directed adenovirus transport and cytoplasmic exploration J Zhou, J Scherer, J Yi, RB Vallee PLoS Pathogens 14 (5), e1007055, 2018 | 41 | 2018 |
| Nuclear herpesvirus capsid motility is not dependent on F-actin JB Bosse, S Virding, SY Thiberge, J Scherer, H Wodrich, Z Ruzsics, ... MBio 5 (5), 10.1128/mbio. 01909-14, 2014 | 37 | 2014 |
| Combined TCR repertoire profiles and blood cell phenotypes predict melanoma patient response to personalized neoantigen therapy plus anti-PD-1 A Poran, J Scherer, ME Bushway, R Besada, KN Balogh, A Wanamaker, ... Cell Reports Medicine 1 (8), 2020 | 36 | 2020 |
| Conformational changes in the adenovirus hexon subunit responsible for regulating cytoplasmic dynein recruitment J Scherer, RB Vallee Journal of virology 89 (2), 1013-1023, 2015 | 31 | 2015 |
| Role of cytoplasmic dynein and kinesins in adenovirus transport J Scherer, J Yi, RB Vallee FEBS letters 594 (12), 1838-1847, 2020 | 29 | 2020 |
| A kinesin-3 recruitment complex facilitates axonal sorting of enveloped alpha herpesvirus capsids J Scherer, IB Hogue, ZA Yaffe, NS Tanneti, BY Winer, M Vershinin, ... PLoS pathogens 16 (1), e1007985, 2020 | 27 | 2020 |
| Dual-color herpesvirus capsids discriminate inoculum from progeny and reveal axonal transport dynamics J Scherer, ZA Yaffe, M Vershinin, LW Enquist Journal of virology 90 (21), 9997-10006, 2016 | 20 | 2016 |
| Exocytosis of alphaherpesvirus virions, light particles, and glycoproteins uses constitutive secretory mechanisms. mBio 7: e00820-16 IB Hogue, J Scherer, LW Enquist, TS Dermody, R Longnecker, P Pellett | 15 | 2016 |
| Functional carboxy-terminal fluorescent protein fusion to pseudorabies virus small capsid protein VP26 IB Hogue, J Jean, AD Esteves, NS Tanneti, J Scherer, LW Enquist Journal of virology 92 (1), 10.1128/jvi. 01193-17, 2018 | 13 | 2018 |
| Adenovirus transport through a direct cytoplasmic dynein-hexon interaction KH Bremner, J Scherer, J Yi, M Vershinin, SP Gross, RB Vallee Cell host & microbe 6 (6), 523, 2009 | 9 | 2009 |
| The personalized vaccine, NEO-PV-01 with anti-PD1, induces neoantigen-specific de novo immune responses in patients with advanced metastatic melanoma: association with clinical … S Hu-Lieskovan, PA Ott, A Naing, RH Besada, SJ Gates, VR Kohler, ... Cancer Research 79 (13_Supplement), 942-942, 2019 | 8 | 2019 |
